
Rabifra D 30mg/20mg Capsule SR
Marketer
Sunfra Biotech
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabifra D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD) is effectively managed with the dual-action formulation Rabifra D 30mg/20mg SR Capsules. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and discomfort by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Rabifra D 30mg/20mg SR Capsules should strictly follow your physician's instructions, tailored to your individual needs and response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is essential to avoid potential interactions. Common, generally transient, side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately to your doctor. Due to potential drowsiness and dizziness, refrain from driving or operating machinery until the medication's effects are known. Alcohol consumption should be avoided to minimize sedation. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to initiating treatment, disclose any pre-existing kidney or liver conditions, and inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Rabifra D 30mg/20mg Capsule SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Rabifra D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabifra D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Rabifra D 30mg/20mg SR Capsule whole; do not crush, chew, or break it. Administer this medicine on an empty stomach.
Common Side effects of Rabifra D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabifra D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rabifra D 30mg/20mg SR Capsules. Ingest the capsule whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.
How Rabifra D 30mg/20mg Capsule SR works:
Rabifra D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to manage gastrointestinal distress. Domperidone, a prokinetic agent, enhances upper gastrointestinal motility, facilitating efficient food transit. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid secretion, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabifra D 30mg/20mg SR capsules concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Rabifra D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Rabifra D 30mg/20mg SR capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rabifra D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Rabifra D 30mg/20mg sustained-release capsules. Dosage modification of Rabifra D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Rabifra D 30mg/20mg SR capsules. Dosage modification may be necessary. A physician's consultation is advised. Rabifra D 30mg/20mg SR capsules are contraindicated in patients experiencing moderate to severe hepatic dysfunction.
What if you forget to take Rabifra D 30mg/20mg Capsule SR :
Should you forget to take a Rabifra D 30mg/20mg Capsule SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabifra D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
